Cargando…
Comparing vision and macular thickness in neovascular age-related macular degeneration, diabetic macular oedema and retinal vein occlusion patients treated with intravitreal antivascular endothelial growth factor injections in clinical practice
OBJECTIVE: To compare the visual outcomes of intravitreal antivascular endothelial growth factor (anti-VEGF) injections in neovascular age-related macular degeneration (nAMD), diabetic macular oedema (DMO) and retinal vein occlusion (RVO) in a real-world setting. METHODS AND ANALYSIS: Retrospective...
Autores principales: | Gurung, Rajya L, FitzGerald, Liesel M, McComish, Bennet J, Hewitt, Alex W, Verma, Nitin, Burdon, Kathryn P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098929/ https://www.ncbi.nlm.nih.gov/pubmed/34013049 http://dx.doi.org/10.1136/bmjophth-2021-000749 |
Ejemplares similares
-
Identifying Genetic Risk Factors for Diabetic Macular Edema and the Response to Treatment
por: Gurung, Rajya L., et al.
Publicado: (2020) -
The effect of insulin on response to intravitreal anti-VEGF injection in diabetic macular edema in type 2 diabetes mellitus
por: Gurung, Rajya L., et al.
Publicado: (2022) -
Predictive factors for treatment outcomes with intravitreal anti-vascular endothelial growth factor injections in diabetic macular edema in clinical practice
por: Gurung, Rajya L, et al.
Publicado: (2023) -
Identifying Genetic Biomarkers Predicting Response to Anti-Vascular Endothelial Growth Factor Injections in Diabetic Macular Edema
por: Gurung, Rajya L., et al.
Publicado: (2022) -
Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study
por: Mitchell, Paul, et al.
Publicado: (2023)